Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain
- PMID: 31158702
- DOI: 10.1016/j.archoralbio.2019.05.028
Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain
Abstract
Objective: This study investigated whether local intramuscular injection of non-psychoactive cannabinoids, cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC) and their combinations can decrease nerve growth factor (NGF)-induced masticatory muscle sensitization in female rats.
Design: In awake rats, changes in mechanical sensitivity induced by intramuscular injection of NGF and cannabinoids were measured by applying an electronic von Frey hair over the masseter muscle to measure the withdrawal response. The effect of CBD (5 mg/ml) and CBN (1 mg/ml) or their combinations CBD/CBN (1:1 mg/ml or 5:1 mg/ml) were assessed. To confirm a peripheral action, electrophysiological experiments were undertaken in anesthetized rats to examine whether intramuscular injections of CBD (5 mg/ml) and CBN (1 mg/ml) altered the mechanical threshold of masticatory muscle mechanoreceptors.
Results: In behavioral experiments, CBD (5 mg/ml) or CBN (1 mg/ml) decreased NGF-induced mechanical sensitization. Combinations of CBD/CBN induced a longer-lasting reduction of mechanical sensitization than either compound alone. No significant change in mechanical withdrawal threshold was observed in the contralateral masseter muscles and no impairment of motor function was found with the inverted screen test after any of the treatments. Consistent with behavioral results, CBD (5 mg/ml), CBN (1 mg/ml) and the combination of CBD/CBN (1:1 mg/ml) increased the mechanical threshold of masseter muscle mechanoreceptors. However, combining CBD/CBN (5:1 mg/ml) at a higher ratio reduced the duration of this effect. This may indicate an inhibitory effect of higher concentrations of CBD on CBN.
Conclusions: These results suggest that peripheral application of these non-psychoactive cannabinoids may provide analgesic relief for chronic muscle pain disorders such as temporomandibular disorders and fibromyalgia without central side effects.
Keywords: Cannabichromene; Cannabidiol; Cannabinoid receptors; Cannabinol; Masseter muscle; Nerve growth factor.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation.Eur J Pain. 2017 Nov;21(10):1732-1742. doi: 10.1002/ejp.1085. Epub 2017 Jul 18. Eur J Pain. 2017. PMID: 28722246
-
Cannabinol and cannabidiol in combination: temperature, open-field activity, and vocalization.Pharmacol Biochem Behav. 1988 Jul;30(3):675-8. doi: 10.1016/0091-3057(88)90082-2. Pharmacol Biochem Behav. 1988. PMID: 3211977
-
Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.Neuroendocrinology. 1990 Oct;52(4):316-21. doi: 10.1159/000125604. Neuroendocrinology. 1990. PMID: 1979838
-
Applications of Cannabinoids in Neuropathic Pain: An Updated Review.Crit Rev Ther Drug Carrier Syst. 2024;41(1):1-33. doi: 10.1615/CritRevTherDrugCarrierSyst.2022038592. Crit Rev Ther Drug Carrier Syst. 2024. PMID: 37824417 Review.
-
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review.Drug Metab Rev. 2014 Feb;46(1):86-95. doi: 10.3109/03602532.2013.849268. Epub 2013 Oct 25. Drug Metab Rev. 2014. PMID: 24160757 Review.
Cited by
-
Strategies to Improve Cannabidiol Bioavailability and Drug Delivery.Pharmaceuticals (Basel). 2024 Feb 13;17(2):244. doi: 10.3390/ph17020244. Pharmaceuticals (Basel). 2024. PMID: 38399459 Free PMC article. Review.
-
Functionally-selective inhibition of threshold sodium currents and excitability in dorsal root ganglion neurons by cannabinol.Commun Biol. 2024 Jan 23;7(1):120. doi: 10.1038/s42003-024-05781-x. Commun Biol. 2024. PMID: 38263462 Free PMC article.
-
Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests.Biomedicines. 2023 Dec 29;12(1):83. doi: 10.3390/biomedicines12010083. Biomedicines. 2023. PMID: 38255191 Free PMC article.
-
Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles.Molecules. 2023 May 24;28(11):4299. doi: 10.3390/molecules28114299. Molecules. 2023. PMID: 37298776 Free PMC article.
-
Preclinical orofacial pain assays and measures and chronic primary orofacial pain research: where we are and where we need to go.Front Pain Res (Lausanne). 2023 May 24;4:1150749. doi: 10.3389/fpain.2023.1150749. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37293433 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
